Literature DB >> 16448698

The presence of the p53 transcripts with truncated open reading frames in Marek's disease tumor-derived cell lines.

Michihiro Takagi1, Kazuhiko Ohashi, Toshifumi Morimura, Chihiro Sugimoto, Misao Onuma.   

Abstract

Several kinds of the p53 transcripts in which their open reading frames (ORFs) were truncated (ranging from 101 to 765 bp) were identified in Marek's disease (MD)-derived tumor cell lines as well as avian leukosis- and reticuloendotheliosis-derived ones, detected by nested RT-PCR and subsequent nucleotide sequence analysis. In these ORFs, regions encoding the proline-rich and DNA-binding domains of the p53 protein were frequently deleted, and many of these deletions were found to cause frame shift. Western blot analysis using anti-p53 monoclonal antibodies revealed that multiple p53 isoform proteins with various molecular weights including 45-46, 35 and 28 kDa were expressed in these tumor cell lines, though the p53 protein with a molecular weight of 49 kDa was detected in chicken embryo fibroblasts transformed by the SV40 T antigen as a control. Since no deletions were found in the p53 gene of these MD tumor cell lines, truncations in the p53 ORFs observed in this study might result from alternative splicing of the p53 gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16448698     DOI: 10.1016/j.leukres.2005.12.009

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  Splicing of mouse p53 pre-mRNA does not always follow the "first come, first served" principle and may be influenced by cisplatin treatment and serum starvation.

Authors:  Min Yang; Jack Wu; Si-Hung Wu; An-Ding Bi; D Joshua Liao
Journal:  Mol Biol Rep       Date:  2012-06-28       Impact factor: 2.316

2.  Detection of p53 mutation and serum monitoring alert caused by Marek's disease virus in poultry.

Authors:  Huixia Zhang; Mengda Liu; Hui Zhang; Shengliang Cao; Yue Li; Shengnan Jiang; Yinuo Song; Sidang Liu
Journal:  BMC Vet Res       Date:  2020-08-24       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.